. . . . . . . . . "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "NQRm3fqeM+eqMa4Qj9cYnjuHvl1BysrbAg4mINWZK2ouxDO9vI4R5DAbQyqteYrmfxSwEPWSypZaf3hx3QwiBliRKic2nTIHBcfcZK5YWAyrNRjdta6EoiOI5CwrQoFm4xc3n6YAjf1A1FiT/oA7ICczFBfsH7MAYp2v1CHkifE=" . . "2021-04-03T11:47:30.850+02:00"^^ . . . . .